Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
68.96 USD | -0.86% | -0.95% | +58.17% |
04-11 | Berenberg Reiterates UCB's Purchase Rating, Raises PT | MT |
04-11 | UCB : Berenberg, Buy, raises its price target | CF |
Sales 2024 * | 5.62B 6.09B 8.33B | Sales 2025 * | 6.33B 6.87B 9.39B | Capitalization | 24.15B 26.19B 35.78B |
---|---|---|---|---|---|
Net income 2024 * | 411M 446M 609M | Net income 2025 * | 860M 933M 1.27B | EV / Sales 2024 * | 4.59 x |
Net Debt 2024 * | 1.64B 1.78B 2.43B | Net Debt 2025 * | 805M 873M 1.19B | EV / Sales 2025 * | 3.94 x |
P/E ratio 2024 * |
60.7
x | P/E ratio 2025 * |
28.2
x | Employees | 8,767 |
Yield 2024 * |
1.11% | Yield 2025 * |
1.13% | Free-Float | 61.44% |
Latest transcript on UCB SA
1 day | -0.86% | ||
1 week | -0.95% | ||
Current month | +4.12% | ||
1 month | +3.74% | ||
3 months | +21.15% | ||
6 months | +85.53% | ||
Current year | +58.17% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | 11-05-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 57 | 20-06-30 |
Chief Tech/Sci/R&D Officer | 63 | 17-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 16-04-27 | |
Dame Davies
BRD | Director/Board Member | 73 | 13-12-31 |
Chief Executive Officer | 65 | 11-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 68.96 | -0.86% | 37,551 |
24-05-24 | 69.56 | -0.13% | 100,584 |
24-05-23 | 69.65 | +1.09% | 10,998 |
24-05-22 | 68.9 | -1.03% | 13,816 |
24-05-21 | 69.62 | +1.27% | 154,295 |
Delayed Quote OTC Markets, May 28, 2024 at 03:52 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.62% | 90.28B | |
-1.97% | 39.5B | |
-15.47% | 31.71B | |
-22.81% | 14.34B | |
-8.82% | 12.89B | |
-11.77% | 11.8B | |
-45.97% | 10.95B | |
+3.30% | 8.85B | |
-15.67% | 7.53B |
- Stock Market
- Equities
- UCB Stock
- UCBJY Stock